The United States pharmaceutical intermediates market is poised for steady growth, with projections indicating a rise from USD 6,591.4 million in 2025 to USD 9,052.8 million by 2035. This expansion reflects a compound annual growth rate (CAGR) of 3.2% during the forecast period from 2025 to 2035. Key factors fueling this growth include the increasing …